(Q40961450)

25 September 2017

Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis (English)

1 reference

25 September 2017

Jasvinder A Singh

12

0 references

Monika M Safford

7

object named as

Monika M Safford

1 reference

25 September 2017

5

Paul Muntner

1 reference

25 September 2017

13

Jeffrey R Curtis

1 reference

25 September 2017

10

James D Lewis

1 reference

25 September 2017

6

Emily B Levitan

1 reference

25 September 2017

Jie Zhang

1

1 reference

25 September 2017

Fenglong Xie

2

1 reference

25 September 2017

Huifeng Yun

3

1 reference

25 September 2017

Lang Chen

4

1 reference

25 September 2017

Shia T Kent

8

1 reference

25 September 2017

Mark T Osterman

9

1 reference

25 September 2017

Kenneth Saag

11

1 reference

25 September 2017

language of work or name

English

0 references

publication date

20 January 2016

1 reference

Annals of the Rheumatic Diseases

25 September 2017

1 reference

25 September 2017

75

1 reference

25 September 2017

1813-1818

1 reference

25 September 2017

10

1 reference

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies

25 September 2017

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

Integrated safety in tocilizumab clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

Tocilizumab in rheumatoid arthritis: a case study of safety evaluations of a large postmarketing data set from multiple data sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

Optimal use of available claims to identify a Medicare population free of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2015-207870

10.1136/ANNRHEUMDIS-2015-207870

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference